Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer

Oncology

Volumn 59, Issue 4, 2000, Pages 310-316

  Ayude, Daniel ^a   Fernández Rodríguez, Julia ^a   Rodríguez Berrocal, Francisco J ^a   Martínez Zorzano, Vicenta S ^a   De Carlos, Alejandro ^a   Gil, Emilio ^a   Páez De La Cadena, María ^a  

^a UNIVERSITY OF VIGO   (Spain)

Author keywords

Alpha L fucosidase; Colorectal cancer; Diagnostic value; Serum; Tumor markers

Indexed keywords

ALPHA LEVO FUCOSIDASE; CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; FLUOROMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0033668430     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012188     Document Type: Article

References (31)

1. Other tumours of the large intestine
2. Sensitivity and specificity of CA242 in gastrointestinal cancer: A comparison with CEA, CA 50 and CA 19-9
3. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma
4. Clinical practice guidelines for the use of tumour markers in breast and colorectal cancer
5. TAG-72 (CA 72-4 assay) as a complementary serum tumour antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer
6. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer
7. Value of carcinoembryonic antigen in the management of colorectal cancer
8. Enzymes in cancer
9. Structure and function of mammalian α-L-fucosidases
10. Serum alpha-L-fucosidase enzyme activity in ovarian and other female genital tract tumours
11. Serum α-L-fucosidase: A new marker for the diagnosis of primary hepatic carcinoma?
12. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Southern African Blacks
13. Serum and tissue α-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma
14. Serum α- L-fucosidase: A more sensitive marker for hepatocellular carcinoma?
15. Serum alpha-L-fucosidase: A useful marker in the diagnosis of hepatocellular carcinoma
16. Serum α-L-fucosidase activity and tumour size in hepatocellular carcinoma
17. Serum α-L-fucosidase activity and early detection of hepatocellular carcinoma
18. The classification of cancer of the rectum
19. Low levels of α-L-fucosidase activity in colorectal cancer are due to decreased amounts of the enzymatic protein and are related with Dukes' stage
20. Alterations of glycosidases in human colonic adenocarcinoma
21. Enzyme Kinetics
22. The use of relative operating characteristic (ROC) curves in test performance evaluation
23. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine
24. pH-dependent association-dissociation of high and low activity plasma α-L-fucosidase
25. Substrate specificity and other properties of α-L-fucosidase from human serum
26. Linkage of plasma α-L-fucosidase (FUCA2) and the plasminogen (PLG) system
27. Plasma lysosomal glycohydrolases in a general population
28. Genetically polymorphic α-L-fucosidase (FUCA1) isozymes detected in blood plasma
29. Plasma α-L-fucosidase activity and the risk of borderline epithelial ovarian tumours
30. Fucose levels in sera and in tumours of colorectal adenocarcinoma patients
31. Homotipic aggregation and terminal glycosilation of cells from dissociated human colorectal tumour tissue